NEW YORK (GenomeWeb News) – Illumina said in a regulatory filing after the close of the market on Thursday that it has received a second request from the US Federal Trade Commission for additional information related to the company’s effort to acquire Complete Genomics.

Separately, BGI-Shenzhen said also on Thursday that it has extended its cash tender offer for Complete Genomics.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.